Axogen, Inc. Cash and Restricted Cash
Axogen, Inc. (AXGN) had Cash and Restricted Cash of $96.57 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-07-29
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $96.57M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $84.65M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $39.55M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $27.90M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $96.57M 10-Q · filed 2026-07-29 |
| 2026-03-31 | $84.65M 10-Q · filed 2026-04-28 |
| 2025-12-31 | $39.55M 10-Q · filed 2026-07-29 |
| 2025-09-30 | $27.90M 10-Q · filed 2025-10-29 |
| 2025-06-30 | $26.04M 10-Q · filed 2026-07-29 |
| 2025-03-31 | $24.10M 10-Q · filed 2026-04-28 |
| 2024-12-31 | $33.55M 10-Q · filed 2026-07-29 |
| 2024-09-30 | $24.66M 10-Q · filed 2025-10-29 |
| 2024-06-30 | $25.19M 10-Q · filed 2025-08-05 |
| 2024-03-31 | $21.71M 10-Q · filed 2025-05-08 |
| 2023-12-31 | $37.03M 10-K · filed 2026-02-24 |
| 2023-09-30 | $37.10M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $29.47M 10-Q · filed 2024-08-08 |
| 2023-03-31 | $13.96M 10-Q · filed 2024-05-02 |
| 2022-12-31 | $21.54M 10-K · filed 2026-02-24 |
| 2022-09-30 | $20.57M 10-Q · filed 2023-11-07 |
| 2022-06-30 | $18.07M 10-Q · filed 2023-08-08 |
| 2022-03-31 | $20.81M 10-Q · filed 2023-05-09 |
| 2021-12-31 | $39.01M 10-K · filed 2025-02-26 |
| 2021-09-30 | $53.06M 10-Q · filed 2022-11-08 |
| 2021-06-30 | $59.41M 10-Q · filed 2022-08-05 |
| 2021-03-31 | $46.18M 10-Q · filed 2022-05-05 |
| 2020-12-31 | $55.61M 10-K · filed 2024-03-05 |
| 2020-09-30 | $67.61M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $85.93M 10-Q · filed 2021-08-05 |
| 2020-03-31 | $41.89M 10-Q · filed 2021-05-06 |
| 2019-12-31 | $41.72M 10-K · filed 2023-03-14 |
| 2019-09-30 | $30.55M 10-Q · filed 2020-10-30 |
| 2019-06-30 | $30.88M 10-Q · filed 2020-08-07 |
| 2019-03-31 | $29.52M 10-Q · filed 2020-05-06 |
| 2018-12-31 | $30.29M 10-K · filed 2022-02-25 |
| 2018-09-30 | $25.63M 10-Q · filed 2019-11-06 |
| 2018-06-30 | $133.56M 10-Q · filed 2019-08-06 |
| 2018-03-31 | $30.56M 10-Q · filed 2019-05-08 |
| 2017-12-31 | $36.51M 10-K · filed 2021-03-01 |
| 2016-12-31 | $30.02M 10-K · filed 2020-02-24 |
| 2015-12-31 | $25.91M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |